John Bridgeman | CSO, Immunokey, UK
"Thanks for the invite to speak at the event. It was a really enjoyable meeting and a great opportunity to present our work to the community. Identifying key partners for ImmunoKey’s development plan is a critical aspect of getting our therapies to patients; the CGT and Biologics Manufacturing DACH meeting offered us the opportunity to engage with key CDMOs who can help us achieve this goal."
Terry Gray | Field Marketing Manager, Merck
"I had the pleasure of collaborating with the IMAPAC team during the Irish leg of the Biologics World event in February 2026. The organisers were exceptionally receptive and helpful, ensuring a seamless experience throughout the planning, exhibition logistics, partnering sessions, and sponsor visibility. Their proactive approach in connecting us with potential partners significantly enhanced our ROI. We are already exploring future opportunities to work with the IMAPAC team."
WHO
For leaders involved in biologics manufacturing, antibody engineering, ADC development, and oligonucleotide & peptide therapeutics across Ireland, the UK and Europe.
WHAT
Three co-located conferences covering Biologics Manufacturing Ireland, Antibody Engineering & ADC Manufacturing Europe, and TIDES Ireland, creating a single platform for the biologics and advanced modalities ecosystem.
WHY
From biologics and ADCs to oligonucleotides and peptides, Ireland continues to attract global investment in advanced therapeutics manufacturing. Connect with the companies, technologies and partners driving the next wave of growth across Europe's biopharma sector.
Senior Attendees
Connect with manufacturing leaders, site heads, engineering directors and technical decision-makers from Ireland, the UK and Europe's leading biologics and advanced therapies organisations.
Expert Speakers
Learn from industry pioneers sharing insights on biologics manufacturing, antibody engineering, ADCs, oligonucleotides, peptides, facility expansion, process innovation and operational excellence.
Companies Represented
Engage with biopharma companies, CDMOs, technology providers, solution partners supporting the growth of Europe's advanced therapeutics ecosystem.
Networking Hours
Build relationships with peers, partners and potential customers through dedicated networking sessions, roundtables and discussions designed to foster collaboration across the industry.
